TOP NEWS: AstraZeneca celebrates EU approval of Lynparza plus Imfinzi
2024年8月14日 - 5:16PM
Alliance News
AstraZeneca PLC on
Wednesday said that the EU approved Imfinzi in combination with
Lynparza for a form of cancer. Th ...
Subscribe now to see this Premium News
article from
Alliance News Professional covers every UK
stock in your portfolio. It goes beyond regulatory news and free
web services to give your investment decisions an edge over the
crowd.
- In The
Know - Management and analyst comments that go beyond company
announcements.
- Flash headlines on all 2,400 London-listed companies before the
news hits the open web.
- Broker Ratings - The
earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and
eurozone.
- Taking
AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £39.60 per month,
and cancel at any time.
Call us on +44 (0) 203 8794 460 to get
started.
Astrazeneca (LSE:AZN)
過去 株価チャート
から 7 2024 まで 8 2024
Astrazeneca (LSE:AZN)
過去 株価チャート
から 8 2023 まで 8 2024